Sofinnova Venture Partners X, L.P. Aerovate Therapeutics, Inc. (AVTE) insider trading activity

Sofinnova Venture Partners X, L.P. is > 10% Shareholder of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 3.76 Million shares of AVTE, which is worth approximately $9.89 Million. The most recent transaction as insider was on Jul 02, 2021, when has been sold 357,142 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $4,999,988. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.76M

0% 3M change

0% 12M change

Total Value Held $9.89 Million

Sofinnova Venture Partners X, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 02 2021	BUY Open market or private purchase	$4,999,988 $14.0 p/Share	357,142 Added 8.68%	3,758,686 Common Stock
Jul 02 2021	BUY Conversion of derivative security	-	3,401,544 Added 50.0%	3,401,544 Common Stock

Also insider at

BOLT

Bolt Biotherapeutics, Inc. Healthcare

> 10% Shareholder

VERA

Vera Therapeutics, Inc. Healthcare

> 10% Shareholder

CINC

CinCor Pharma, Inc. Healthcare

> 10% Shareholder

SVP